TLR4 and COVID-19: Let-7b can potentially enhance the synthesis of inflammatory cytokines, activating TLR4/NF-κB pathway and inhibiting the TLR4 expression, which in COVID-19 patients may be interesting especially in neutrophils, due to their role in sepsis development.